ReNeuron

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ReNeuron
Public company
Traded as LSERENE
Industry Stem cell research & development
Founded 1997
Headquarters Surrey, England, UK
Website reneuron.com

ReNeuron is a UK-based stem cell research company whose shares are listed on the Alternative Investment Market. Its focus is on the development of stem-cell therapies targeting areas of poorly-met medical need, including peripheral arterial disease, strokes, and retinal diseases.

ReNeuron is currently testing the effects of neural stem cells on spinal cords for neuroregeneration.[1] They are also testing the use of fetal stem cells on stroke patients.[2]

See also[edit]

References[edit]

  1. ^ Cookson, Clive (4 May 2010). "Regenerative medicine: Possibilities multiply for nerve cell regrowth". Retrieved 23 May 2010. 
  2. ^ "EU agency prepares to assess first stem cell drug". Reuters. 12 May 2010. Retrieved 23 May 2010. 

External links[edit]